Production of Soluble Human Vascular Endothelial Growth Factor VEGF-A165-Heparin Binding Domain in Escherichia coli

Seyedarabi, Arefeh; Cheng, Lili; Zachary, Ian; Djordjevic, Snezana
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
We report a method for production of soluble heparin binding domain (HBD) of human vascular endothelial growth factor VEGF-A165. Recombinant VEGF-A165-HBD that contains four disulphide bridges was expressed in specialised E. coli SHuffle cells and its activity has been confirmed through interactions with neuropilin and heparin. The ability to produce significant quantities of a soluble active form of VEGF-A165-HBD will enable further studies addressing the role of VEGF-A in essential processes such as angiogenesis, vasculogenesis and vascular permeability.


Related Articles

  • Inhibition of Angiogenesis by Recombinant VEGF Receptor Fragments. Ahmadvand, Davoud // Laboratory Medicine;Jul2010, Vol. 41 Issue 7, p417 

    BACKGROUND: Blocking vascular endothelial growth factor receptor (VEGFR) is a successful approach for inhibiting vascular endothelial growth factor (VEGF) signaling. Small molecules impairing the interaction of VEGF with VEGF receptors have been synthesized and evaluated in this research....

  • APE1/Ref-1Role in Redox Signaling: Translational Applications of Targeting the Redox Function of the DNA Repair/Redox Protein APE1/Ref-1. Kelley, Mark R.; Georgiadis, Millie M.; Fishel, Melissa L. // Current Molecular Pharmacology;Jan2012, Vol. 5 Issue 1, p36 

    The heterogeneity of most cancers diminishes the treatment effectiveness of many cancer-killing regimens. Thus, treatments that hold the most promise are ones that block multiple signaling pathways essential to cancer survival. One of the most promising proteins in that regard is APE1, whose...

  • Modulation of factors involved in placental haemostasis and angiogenesis by low-molecular-weight-heparins. Grandone, Elvira; Chinni, Elena; Villani, Michela; Sciannamè, Natale; Tiscia, Giovanni; Favuzzi, Giovanni; Cappucci, Filomena; Petruzzelli, Francesco; Margaglione, Maurizio // Archives of Gynecology & Obstetrics;Nov2016, Vol. 294 Issue 6, p1323 

    Purpose: In placentae from uneventful pregnancies a direct relationship between expression of tissue factor (TF) and tissue-factor pathway inhibitor type 2 (TFPI2) was found, as well as between TF and vascular endothelial growth factor (VEGF). Furthermore, placentae from gestational vascular...

  • Construction of multi-functional extracellular matrix proteins that inhibits migration and tube formation of endothelial cells. Nakamura, Makiko; Mie, Masayasu; Nakamura, Makoto; Kobatake, Eiry // Biotechnology Letters;Aug2012, Vol. 34 Issue 8, p1571 

    Artificial extracellular matrix (ECM) proteins have been designed that have strong cell-adhesive activity and active functional units that inhibit network formation among vascular endothelial cells. A laminin-derived sequence (YIGSR) that blocks migration of vascular endothelial cells was...

  • Production and on-column re-folding of human vascular endothelial growth factor 165 in Escherichia coli. Bang, Sun; Kim, Young; Chang, Byung; Park, Cheol; Bang, In // Biotechnology & Bioprocess Engineering;Sep2013, Vol. 18 Issue 5, p835 

    Vascular endothelial growth factors (VEGFs) are a family of proteins that promote angiogenesis and participate in a variety of physiological and pathological processes. In this work, the gene encoding the human VEGF isoform 165 (hVEGF) was cloned into the expression vector pET32a (+) to...

  • NGR Enhanced the Anti-Angiogenic Activity of tum-5. Jieru Meng; Nan Ma; Zhen Yan; Wei Han; Yingqi Zhang // Journal of Biochemistry;Aug2006, Vol. 140 Issue 2, p299 

    Tumstatin is an angiogenesis inhibitor. The anti-angiogenic activity of tumstatin is localized to the 54–132 amino acids. NGR motif is a marker of angiogenic endothelial cells. We synthesized the gene fragment encoding the amino acids 45–132 of tumstatin (tum-5) and coupled a NGR...

  • Cytotoxic Effect of Immunotoxin Containing The Truncated Form of Pseudomonas Exotoxin A and Anti-VEGFR2 on HUVEC and MCF-7 Cell Lines. Safari, Elahe; Hosseini, Ahmad Zavaran; Hassan, Zuhair; Khajeh, Khosro; Ardestani, Mehdi Shafiee; Baradaran, Behzad // Cell Journal (Yakhteh);Summer2014, Vol. 16 Issue 2, p203 

    Objective: Immunotoxins (ITs) have been developed for the treatment of cancer, and comprise of antibodies linked to toxins. Also vascular endothelial growth factor (VEGF) plays a key role in tumor angiogenesis, and the blockade of VEGF receptor- 2 (VEGFR2) inhibits angiogenesis and tumor growth....

  • In vitro models for the evaluation of angiogenic potential in bone engineering. Cenni, Elisabetta; Perut, Francesca; Baldini, Nicola // Acta Pharmacologica Sinica;Jan2011, Vol. 32 Issue 1, p21 

    Blood vessels have a fundamental role both in skeletal homeostasis and in bone repair. Angiogenesis is also important for a successful bone engineering. Therefore, scaffolds should be tested for their ability to favour endothelial cell adhesion, proliferation and functions. The type of...

  • Expression and Purification of Functional Human Vascular Endothelial Growth Factor-A121; the Most Important Angiogenesis Factor. Kazemi-Lomedasht, Fatemeh; Behdani, Mahdi; Bagheri, Kamran Pooshang; Anbouhi, Mahdi Habibi; Abolhassani, Mohsen; Khanahmad, Hossein; Shahbazzadeh, Delavar; Mirzahoseini, Hasan // Advanced Pharmaceutical Bulletin;2014, Vol. 4 Issue 4, p323 

    Purpose: Angiogenesis or formation of new blood vessels is an essential process for tumor growth, invasion and metastasis. Vascular Endothelial Growth Factor (VEGF) and its receptors play an important role in angiogenesis-dependent tumors. VEGF-A is the most important factor in angiogenesis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics